High-risk multiple myeloma: different definitions, different outcomes?

Paszekova, Helena; Kryukov, Fedor; Kubiczkova, Lenka; Hajek, Roman; Sevcikova, Sabina

Paszekova, Helena; Kryukov, Fedor; Kubiczkova, Lenka; Hajek, Roman; Sevcikova, Sabina.

Afiliación

Paszekova H; Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Kryukov F; Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
Kubiczkova L; Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic; Department of Clinical Hematology, University Hospital Brno, Czech Republic.
Hajek R; Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic; Department of Clinical Hematology, University Hospital Brno, Czech Republic.
Sevcikova S; Babak Myeloma Group, Department of Pathological Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic; Department of Clinical Hematology, University Hospital Brno, Czech Republic. Electronic address: sevcik@med.muni.cz.

Clin Lymphoma Myeloma Leuk ; 14(1): 24-30, 2014 Feb.

Article en En | MEDLINE | ID: mdl-24225331

Asunto(s)

Mieloma Múltiple/terapia; Citogenética/métodos; Humanos; Mieloma Múltiple/genética; Mieloma Múltiple/patología; Recurrencia Local de Neoplasia/patología; Pronóstico; Riesgo

Palabras clave

Cytogenetics; GEP; High-risk disease; MGUS; Multiple myeloma; Prognosis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Mieloma Múltiple Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Lymphoma Myeloma Leuk Asunto de la revista: NEOPLASIAS Año: 2014 Tipo del documento: Article País de afiliación: República Checa

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google